Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Study identifies effects of multiple previous concussions on high school students

A previous study of ex-NFL players showed that the damage caused by concussions occurs in the same region of the brain as damage caused by Alzheimer's disease, resulting in increased concern over post-concussion related injuries and trauma of athletes. Philip Schatz Ph.D., professor of psychology, and his associates recently published a study in Neurosurgery that identifies potentially enduring effects of multiple previous concussions on high school students.

2 Feb 2011

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

A targeted delivery combination selectively crosses the tight barrier that protects the brain from the bloodstream to home in on and bind to brain tumors, a research team led by scientists from The University of Texas MD Anderson Cancer Center reported in the January issue of the Journal of Clinical Investigation.

2 Feb 2011

Research identifies potential reversibility of chronic neurologic disability in stroke survivors

A breakthrough in stroke research identifying the potential reversibility of chronic neurologic disability in stroke survivors has published today. In the February 1, 2011 issue of the journal CNS Drugs the first human results of a new method of targeting chronic brain inflammation years after stroke are reported.

2 Feb 2011

Multi-national group of researchers announce launch of International Genomics of Alzheimer's Project

The launch of the International Genomics of Alzheimer's Project (IGAP) - a collaboration formed to discover and map the genes that contribute to Alzheimer's disease - was announced today by a multi-national group of researchers including Drs. Lindsay Farrer and Sudha Seshadri at Boston University School of Medicine (BUSM). The collaborative effort, spanning universities from both sides of the Atlantic, will combine the knowledge, staff and resources of four consortia that work on Alzheimer's disease genetics.

2 Feb 2011

Higher intake of monounsaturated, polyunsaturated fatty acids reduce risk of mild cognitive impairment

Mayo Clinic researchers found that the prevalence of mild cognitive impairment decreased with an increase in the consumption of monounsaturated and polyunsaturated fatty acids. Monounsaturated fatty acids are commonly found in olive oil and canola oils, and polyunsaturated fatty acids, such as Omega 3 or Omega 6 fatty acids, are commonly found in most varieties of nuts, seeds and fish.

2 Feb 2011

Defective nucleoli linked to Parkinson's disease

"Nucleolus", or small nucleus, is the term coined by early biologists for the tiny structure within the nucleus which they saw under the microscope. In this structure within the nucleus, RNA molecules and proteins are assembled to form ribosomes, the true protein factories of cells.

2 Feb 2011

Vanderbilt researchers announce multi-national collaboration on Alzheimer's disease genetics

Researchers at Vanderbilt University Medical Center, and across the globe, announced today a multi-national collaboration to discover and map all genes relating to Alzheimer's disease through the formation of the International Genomics of Alzheimer's Project.

1 Feb 2011

Biogen Idec 2010 total revenues increase 8% to $4.7 billion

Biogen Idec Inc., a global biotechnology leader in the discovery, development, manufacturing, and commercialization of innovative therapies, today announced its full year and fourth quarter 2010 results.

1 Feb 2011

PhRMA: 299 medicines under development for prevention and treatment of heart disease and stroke

An American dies of heart disease every 39 seconds, and African Americans suffer a higher death rate from heart disease and stroke than Americans overall. Partly as a result of having the highest prevalence of high blood pressure in the world, African Americans have a 1.5 times greater rate of heart disease death than other Americans and a 1.8 times greater rate of fatal stroke.

1 Feb 2011

Software can predict future of sports concussion: New research

With the Pittsburgh Steelers and Green Bay Packers poised to do battle for the Super Bowl XLV crown, concern about recognizing and minimizing the incidence of concussions in sports could once again be back in the spotlight. Media coverage of concussion awareness rose to a fever pitch earlier this season fueled by an Associated Press report that this type of traumatic brain injury (TBI) had risen 21 percent in the first eight weeks of the regular season.

1 Feb 2011

Global consortium aims to discover and map all Alzheimer's genes

The launch of the International Genomics of Alzheimer's Project (IGAP) – a collaboration formed to discover and map the genes that contribute to Alzheimer's disease – was announced today by a multi-national group of researchers. The collaborative effort, spanning universities from both Europe and the United States, will combine the knowledge, staff and resources of four consortia that conduct research on Alzheimer's disease genetics.

1 Feb 2011

Walk briskly to boost memory

Researchers have found that older adults who took a brisk walk three times a week did better on memory tests and increased the size of their hippocampus, a portion of the brain involved with memory formation.

1 Feb 2011

Positive results from NRM8499 phase I clinical study in patients with Alzheimer's disease

BELLUS Health announced today the results of the phase I clinical study for NRM8499, a prodrug of tramiprosate, intended for the treatment of Alzheimer's disease.

1 Feb 2011

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

AVANIR Pharmaceuticals, Inc. today announced that NUEDEXTA™ (dextromethorphan hydrobromide and quinidine sulfate) is now available by prescription in the United States. NUEDEXTA is the first and only treatment approved by the U.S. Food and Drug Administration (FDA) for pseudobulbar affect (PBA).

1 Feb 2011

New research finding shows strong relationship between gut bacteria and fatty liver

The more we learn about biology, the closer we get to being able to treat disease - and the more complicated our understanding of disease itself becomes. A new research finding showing a strong relationship between complex microbial ecologies in human intestines and the common but serious medical condition known as fatty liver illustrates this paradox.

1 Feb 2011

Venture philanthropist invests $3.5 million to thwart Alzheimer's disease

Retired San Francisco real estate developer Douglas Rosenberg says he has a new job - helping to find a cure for Alzheimer's disease. Through the Ellen and Douglas Rosenberg Foundation, the venture philanthropist is betting at least $3.5 million that Buck faculty Dale Bredesen, MD has the correct take on how to thwart the memory robbing disease that affects over 5 million Americans.

31 Jan 2011

Scientists convert adult skin cells into cardiomyocytes using direct reprogramming strategy

Scripps Research Institute scientists have converted adult skin cells directly into beating heart cells efficiently without having to first go through the laborious process of generating embryonic-like stem cells. The powerful general technology platform could lead to new treatments for a range of diseases and injuries involving cell loss or damage, such as heart disease, Parkinson's, and Alzheimer's disease.

30 Jan 2011

HPN President announces gift to UCLA to advance research for Neural Regeneration

Dr. Richard Merkin, President and CEO of Heritage Provider Network, and the Merkin Family Foundation announce the generous gift to the UCLA Department of Neurology at the David Geffen School of Medicine at UCLA to advance research for Neural Regeneration.

29 Jan 2011

Elderly Americans most likely to have one or more cognitive disorders: AHRQ

Slightly over 5 percent of the nearly 39 million Americans age 65 and older in 2007 reported one or more cognitive disorders, such as senility or dementia, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

29 Jan 2011

Adeona to sell 2.85 million common stock at $1.40 per share

Adeona Pharmaceuticals, a developer of innovative medicines for serious central nervous system diseases, announced today that it has executed an agreement for the sale of approximately 2.85 million shares of its common stock at $1.40 per share to two new institutional investors in a registered direct offering for $4 million in gross proceeds.

29 Jan 2011

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Study identifies effects of multiple previous concussions on high school students

Targeted delivery combination crosses brain protecting barrier and homes in on tumors

Research identifies potential reversibility of chronic neurologic disability in stroke survivors

Multi-national group of researchers announce launch of International Genomics of Alzheimer's Project

Higher intake of monounsaturated, polyunsaturated fatty acids reduce risk of mild cognitive impairment

Defective nucleoli linked to Parkinson's disease

Vanderbilt researchers announce multi-national collaboration on Alzheimer's disease genetics

Biogen Idec 2010 total revenues increase 8% to $4.7 billion

PhRMA: 299 medicines under development for prevention and treatment of heart disease and stroke

Software can predict future of sports concussion: New research

Global consortium aims to discover and map all Alzheimer's genes

Walk briskly to boost memory

Positive results from NRM8499 phase I clinical study in patients with Alzheimer's disease

AVANIR's NUEDEXTA for pseudobulbar affect now available by prescription

New research finding shows strong relationship between gut bacteria and fatty liver

Venture philanthropist invests $3.5 million to thwart Alzheimer's disease

Scientists convert adult skin cells into cardiomyocytes using direct reprogramming strategy

HPN President announces gift to UCLA to advance research for Neural Regeneration

Elderly Americans most likely to have one or more cognitive disorders: AHRQ

Adeona to sell 2.85 million common stock at $1.40 per share

eBook: Hallmarks of Neurodegeneration eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Hallmarks of Neurodegeneration eBook

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in